With skyrocketing demand for semaglutide and tirzepatide (popularized under brand names Ozempic, Wegovy, Zepbound, and Mounjaro), the stage was set for a compounding boom
The study suggests that GLP-1, typically used to treat diabetes and obesity, could be explored as a potential treatment for SUD by reducing cravings and managing substance-seeking behaviors
They are often not told this upfront and, with many people stopping these drugs after only two years due to this misunderstanding, high costs, and side effects, it can lead to them possibly giving up on weight loss all together
[DOI] [PMC free article] [PubMed] [Google Scholar] 24.Eberly LA, Yang L, Eneanya ND, et al
Although in most cases, they are quite successful in producing substantial weight loss, many have regained weight after the medication was discontinued
Liposome liquid form may offer faster absorption